Optimal frequency for measuring health care resource utilization in Parkinson's disease using participant recall: The FS-TOO resource utilization substudy

Clinical Therapeutics

Volumn 30, Issue 8, 2008, Pages 1553-1557

  Mauldin, Patrick D ^a   Guimaraes, Paulo ^a   Albin, Roger L ^b   Ray Dorsey, E ^c   Bainbridge, Jacquelyn L ^d   Siderowf, Andrew ^e  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

clinical trials; health care resources; Parkinson's disease

Indexed keywords

1 (3,3 DIMETHYL 1,2 DIOXOPENTYL) 2 PYRROLIDINECARBOXYLIC ACID 3 (3 PYRIDYL)PROPYL ESTER; UBIDECARENONE;

ADULT; AGED; ARTICLE; BRADYKINESIA; CLINICAL TRIAL; DISEASE SURVEILLANCE; FEMALE; HEALTH CARE UTILIZATION; HEALTH SERVICE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PATIENT CARE; PATIENT PARTICIPATION; PRIMARY MEDICAL CARE; QUESTIONNAIRE; RECALL; RESEARCH SUBJECT; RESOURCE ALLOCATION; RIGIDITY; SELF REPORT; TREMOR; UNIFIED PARKINSON DISEASE RATING SCALE;

ADULT; AGED; AGED, 80 AND OVER; DATA COLLECTION; FEMALE; HEALTH SERVICES; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; REPRODUCIBILITY OF RESULTS;

EID: 51549085435     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2008.08.001     Document Type: Article

References (10)

1. Noyes K., Liu K., Li Y., et al. Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries. Mov Disord. 21 (2006) 362-372
2. Epstein A.M., Seage III G., Weissman J.S., et al. Costs of medical care and out-of-pocket expenditures for persons with AIDS in the Boston Health Study. Inquiry. 32 (1995) 211-221
3. Killeen T.K., Brady K.T., Gold P.B., et al. Comparison of selfreport versus agency records of service utilization in a community sample of individuals with alcohol use disorders. Drug Alcohol Depend. 73 (2004) 141-147
4. Tourangeau R., and Rasinski K.A. Evaluation of Data Collection Frequency and the Use of a Summary in the National Medical Utilization and Expenditure Survey, Series A (1987), US Government Printing Office, Washington, DC
5. Tilley B.C., Palesch Y.Y., Kieburtz K., et al., for the NET-PD Investigators. Optimizing the ongoing search for new treatments for Parkinson disease: Using futility designs. Neurology. 66 (2006) 628-633
6. The NINDS NET-PD Investigators. A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease. Neurology. 68 (2007) 20-28
7. Shapiro M.F., Morton S.C., McCaffrey D.F., et al. Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study. JAMA. 281 (1999) 2305-2315
8. Perez G., MacArthur R.D., Walmsley S., et al., for the Terry Beirn Community Programs for Clinical Research on AIDS; Canadian Trials Network. A randomized clinical trial comparing nelfinavir and ritonavir in patients with advanced HIV disease (CPCRA 042/CTN 102). HIV Clin Trials. 5 (2004) 7-18
9. Lin L.I. A concordance correlation coefficient to evaluate reproducibility. Biometrics. 45 (1989) 255-268
10. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 20 (1960) 37-46